340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers That Their Contract Pharmacy Actions Violate 340B Statute

Publication Date27 May 2021
SubjectManufacturers,Warning Letters,HRSA,Section 340B,Drug Pricing,Pharmaceutical Industry,Department of Health and Human Services (HHS)
AuthorRichard Church,Maggie Power,Elaine Naughton
Law FirmK&L Gates LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT